SG Americas Securities’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,345
| Closed | -$379K | – | 3500 |
|
|
2022
Q3 | $379K | Sell |
7,345
-16,883
| -70% | -$698K | ﹤0.01% | 1788 |
|
|
2022
Q2 | $600K | Sell |
24,228
-16,565
| -41% | -$365K | 0.01% | 1801 |
|
|
2022
Q1 | $1.02M | Buy |
40,793
+9,094
| +29% | +$256K | 0.01% | 1409 |
|
|
2021
Q4 | $1.15M | Sell |
31,699
-55,417
| -64% | -$1.95M | 0.01% | 1549 |
|
|
2021
Q3 | $1.49M | Sell |
87,116
-38,557
| -31% | -$601K | 0.01% | 1545 |
|
|
2021
Q2 | $1.68M | Buy |
125,673
+69,505
| +124% | +$1.71M | 0.01% | 1227 |
|
|
2021
Q1 | $2.88M | Sell |
56,168
-30,397
| -35% | -$1.83M | 0.02% | 814 |
|
|
2020
Q4 | $5.36M | Buy |
86,565
+42,366
| +96% | +$2.43M | 0.03% | 468 |
|
|
2020
Q3 | $2.42M | Buy |
44,199
+34,811
| +371% | +$1.87M | 0.02% | 637 |
|
|
2020
Q2 | $540K | Sell |
9,388
-5,084
| -35% | -$277K | ﹤0.01% | 2032 |
|
|
2020
Q1 | $581K | Sell |
14,472
-2,889
| -17% | -$123K | 0.01% | 1725 |
|
|
2019
Q4 | $687K | Sell |
17,361
-8,057
| -32% | -$141K | 0.01% | 1533 |
|
|
2019
Q3 | $172K | Buy |
25,418
+5,247
| +26% | +$39.4K | ﹤0.01% | 2429 |
|
|
2019
Q2 | $188K | Sell |
20,171
-69
| -0.3% | -$799 | ﹤0.01% | 2450 |
|
|
2019
Q1 | $281K | Buy |
20,240
+2,269
| +13% | +$25.9K | ﹤0.01% | 2324 |
|
|
2018
Q4 | $196K | Buy |
+17,971
| New | +$190K | ﹤0.01% | 2401 |
|
|
2018
Q1 | – | Sell |
-13,113
| Closed | -$78K | – | 3640 |
|
|
2017
Q4 | $78K | Buy |
13,113
+3,109
| +31% | +$21.3K | ﹤0.01% | 2908 |
|
|
2017
Q3 | $74K | Buy |
+10,004
| New | +$83.2K | ﹤0.01% | 3259 |
|
|
2017
Q1 | – | Sell |
-18,467
| Closed | -$137K | – | 3635 |
|
|
2016
Q4 | $137K | Buy |
+18,467
| New | +$133K | ﹤0.01% | 2643 |
|
|
2015
Q1 | – | Sell |
-14,644
| Closed | -$100K | – | 3176 |
|
|
2014
Q4 | $100K | Sell |
14,644
-5,458
| -27% | -$28.9K | ﹤0.01% | 2927 |
|
|
2014
Q3 | $90K | Buy |
+20,102
| New | +$106K | ﹤0.01% | 2399 |
|
|
2014
Q2 | – | Sell |
-12,653
| Closed | -$84K | – | 2755 |
|
|
2014
Q1 | $84K | Buy |
+12,653
| New | +$87.9K | ﹤0.01% | 2249 |
|
Other funds holding CCXI
SG Americas Securities's CCXI Position: Q4 2022 in Review
SG Americas Securities sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,345 shares — an estimated $379K sold.
SG Americas Securities first reported a position in CCXI in Q1 2014 and held it in 22 quarters. The position peaked at $5.36M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- SG Americas Securities reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- SG Americas Securities sold 7,345 ChemoCentryx, Inc. shares in Q4 2022, an estimated $379K.
- SG Americas Securities first reported a position in ChemoCentryx, Inc. in Q1 2014 and held it in 22 quarters.
- SG Americas Securities's ChemoCentryx, Inc. position peaked at $5.36M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.